Mindaugas Zekonis, MD
Nephrology · Indianapolis, INNPI 1114982642
Payments from drug & device makers
Across 36 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$437
- Amgen$177
- Aurinia Pharma U.S., Inc.$57
- Otsuka America Pharmaceutical, Inc.$33
- Vifor Pharma, Inc.$19
What the payments were for
- Food & beverage$723100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 20 | $437 |
| Amgen | 11 | $177 |
| Aurinia Pharma U.S., Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Vifor Pharma, Inc. | 1 | $19 |
How this compares
$723 in reported general payments places this provider in the 45th percentile of 238 nephrology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 49 | $47,433 |
| RenvelaSevelamer Carbonate | 15 | $35,926 |
| FarxigaDapagliflozin Propanediol | 28 | $30,147 |
| Sevelamer Carbonate | 26 | $11,948 |
| Potassium Citrate ErPotassium Citrate | 29 | $9,827 |
| Torsemide | 172 | $5,301 |
| Potassium Chloride | 55 | $2,364 |
| Allopurinol | 171 | $2,134 |
| Nifedipine ErNifedipine | 42 | $1,748 |
| Losartan Potassium | 210 | $1,577 |
| Metoprolol Succinate | 74 | $961 |
| Metolazone | 14 | $881 |
| Carvedilol | 87 | $752 |
| Amlodipine Besylate | 158 | $743 |
| Calcitriol | 32 | $674 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Indianapolis
- Rajiv AgarwalIndianapolis$1.2M
- Jay WishIndianapolis$502K
- Bruce MolitorisIndianapolis$471K
- Arjun SinhaIndianapolis$315K
- Sharon MoeIndianapolis$298K
- Kenneth LimIndianapolis$238K
- Tim TaberIndianapolis$198K
- Melissa AndersonIndianapolis$146K
- Asif SharfuddinIndianapolis$146K
- Michael KrausIndianapolis$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.